Post Job

PacBio main competitors are Personalis, Vertex Pharmaceuticals, and Illumina.

Competitor Summary. See how PacBio compares to its main competitors:

  • Sanofi Genzyme has the most employees (12,000).
  • Employees at Personalis earn more than most of the competitors, with an average yearly salary of $102,719.
Work At PacBio?
Share Your Experience

PacBio vs competitors

CompanyFounding DateZippia ScoreHeadquarters# of LocationsRevenueEmployees
2004
4.7
Menlo Park, CA1$128.3M400
1998
4.4
Alameda, CA1-750
1989
4.6
Boston, MA5$8.9B3,400
1995
4.5
Hopkinton, MA1$109.8M200
1979
4.7
San Diego, CA3$1.7B1,500
2014
4.4
Cambridge, MA1$52.1M211
1947
4.4
Rockville, MD4$49.9M700
2002
4.8
Cambridge, MA2$1.0B1,323
1998
4.8
San Diego, CA5$4.6B7,800
Geron
1990
4.6
Menlo Park, CA3$596,00015
2002
4.0
Gaithersburg, MD1$2.6M48
1995
4.7
Austin, TX3$417.4M1,140
1987
4.7
Gaithersburg, MD1$422.2M6,030
1959
4.8
Bedford, MA2$1.0B3,000
1987
4.5
Irvine, CA1$83.0M1,074
McNeil Consumer Healthcare
1879
4.3
Fort Washington, PA1$46.2M17
2001
4.3
Salem, NH1$29.5M115
Medical Device Company
-
4.5
----
1994
3.7
Columbia, MD1$3.1M200
2011
4.4
Menlo Park, CA1$65.0M147
1981
4.8
Cambridge, MA1$4.6B12,000

Rate how well PacBio differentiates itself from its competitors.

Zippia waving zebra

PacBio salaries vs Competitors

Among PacBio competitors, employees at Personalis earn the most with an average yearly salary of $102,719.

Compare PacBio Salaries VS Competitors

CompanyAverage SalaryHourly SalarySalary Score
PacBio
$93,409$44.91-
Celera
$75,834$36.46-
Vertex Pharmaceuticals
$95,952$46.13-
Caliper Life Sciences
$81,030$38.96-
Quidel
$71,489$34.37-
Intellia Therapeutics
$79,975$38.45-

Compare PacBio Job Title Salaries VS Competitors

CompanyHighest SalaryHourly Salary
PacBio
$60,121$28.90
McNeil Consumer Healthcare
$92,483$44.46
Sanofi Genzyme
$91,746$44.11
AgaMatrix
$91,224$43.86
Quidel
$91,024$43.76
Geron
$90,574$43.55
Advanced Sterilization Products
$90,242$43.39
Vertex Pharmaceuticals
$89,547$43.05
Medimmune
$84,409$40.58
Medical Device Company
$84,148$40.46
Instrumentation Laboratory
$83,720$40.25
Illumina
$80,354$38.63
OpGen
$72,976$35.08
Intellia Therapeutics
$72,643$34.92
CyLex
$72,464$34.84
Personalis
$72,283$34.75
Luminex
$72,028$34.63
Celera
$70,522$33.90
BioReliance
$70,492$33.89
Alnylam Pharmaceuticals
$69,161$33.25

Do you work at PacBio?

Is PacBio able to compete effectively with similar companies?

PacBio Jobs

PacBio demographics vs competitors

Compare Gender At PacBio Vs Competitors

Job TitleMaleFemale
Geron44%56%
Alnylam Pharmaceuticals49%51%
Luminex59%41%
Illumina62%38%
OpGen64%36%
PacBio65%35%
Male
Female
100%
75%
50%
25%
0%
0%
25%
50%
75%
100%

Compare Race At PacBio Vs Competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity Score
42%20%5%27%5%
9.6
59%14%5%16%6%
9.1
Geron
46%20%7%22%4%
9.2
46%23%7%20%5%
9.7
48%23%11%14%3%
9.8
53%7%18%20%2%
7.1

PacBio REVENUE Vs Competitors

  • PacBio
  • Alnylam Pharmaceuticals
  • Geron
  • Illumina

PacBio And Similar Companies CEOs

CEOBio
Yvonne L. Greenstreet
Alnylam Pharmaceuticals

Yvonne Greenstreet is a COO at ALNYLAM PHARMACEUTICALS, INC..

John A. Scarlett M.d
Geron

John 'Chip' Scarlett is a Co-Founder at Covance and Board Member at CYTOMX THERAPEUTICS, INC. and is based in Menlo Park, California. He has worked as Board Member at GERON CORP, Board Member at Chiasma Inc, and Adjunct Assistant Professor of Medicine at Hospital of the University of Pennsylvania. John works or has worked as Various Positions at Mcneil Pharmaceuticals and Dir:Medical Research & Svcs at Mcneil Pharmaceuticals. He studied at University of Colorado Boulder between 1980 and 1982, University of Chicago - The Pritzker School of Medicine between 1973 and 1977, and Earlham College between 1969 and 1973.

Francis A. Desouza
Illumina

Francis Aurelio deSouza (born December 2, 1970) is an American entrepreneur and business executive. He is the president and chief executive officer (CEO) of Illumina and a member of the Board of Directors of The Walt Disney Company.

Nachum Shamir
Luminex

With a proven track record of bringing game-changing technologies to the market, Mr. Shamir joined Luminex Corporation as President, Chief Executive Officer, and Board Member in 2014. From 2006 to 2014, Mr. Shamir served as President and CEO of Given Imaging, a developer, manufacturer, and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract, which was acquired by Covidien PLC in early 2014. Mr. Shamir currently serves on the board of directors of Exalenz Bioscience Ltd. (TASE: EXEN). He has previously served as a Board Member at Scitex Corporation, Cogentix Medical (NASDAQ: CGNT), recently acquired by Laborie Medical Technologies, and invendo medical GmBH, now part of Ambu. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.

Evan Jones
OpGen

Douglas C. Bryant
Quidel

Douglas C. Bryant became President and Chief Executive Officer on March 1, 2009. Prior to joining Quidel, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics (Toronto), manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, he held various worldwide commercial operations positions with Abbott Laboratories including, among others: Vice President of Abbott Vascular for Asia/Japan, Vice President of Abbott Molecular Global Commercial Operations and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa, and Vice President of Diagnostic Operations Asia Pacific. Mr. Bryant holds a B.A. in Economics from the University of California at Davis.

Reshma Kewalramani M.d
Vertex Pharmaceuticals

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Skip Wagner
BioReliance

Skip Wagner is a President and Chief Executive Officer at BioReliance and is based in College Station, Texas.

Paul Hudson
Sanofi Genzyme

Speck Loe
Medimmune

Speck Loe works at Medimmune and a Ceo at Medimmune and is based in Granite Falls, Washington.

What employees say about PacBio's competitors

Employee Reviews
profile
1.0
A zippia user wrote a review on Apr 2024
Cons of working at PacBio

1.They believe they can increase their sales of products to the target audience of research labs and scientists by investing in organizing concerts and paying off celebrities/singers, followed by laying off their technical workforce. (Basic marketing skills in question.) 2. There is less focus on adopting DEI initiatives. 3. Layoffs occur every six months. 4. Upper management exhibits nepotism towards people from the Bay Area (headquarter) more than the San Diego office, leaving no scope for innovation. Middle management doesn't do a good job to advocate for individual contribution to the upper management. If you are from San Diego you have to work harder than from Menlo Park office to get visibility. 5. Middle and some people in upper management will walk by you without greeting back, even if you try to smile and greet them. Initially, I thought it might be a cultural thing, but observing them interact with direct reports only and not with people below them indicates that they have a vertical hierarchy in place.

Pros of working at PacBio

Cutting edge technology but I worry to be in the hands of wrong and incapable management.

Is this useful?
Work at PacBio? Share your experience

PacBio Competitors FAQs

Search for jobs